• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSS2000021 美泊利单抗注射液 mepolizumab Injection Biological Products Import Drug Application 2020-07-06 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2021-11-19 view
JXSL2000148 美泊利单抗注射液 mepolizumab Injection Biological Products(2.2) Import Drug Application 2020-09-09 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review 2020-09-08 view
JXSL2000004 美泊利单抗注射液 mepolizumab Injection Biological Products Import Drug Application 2020-01-18 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review 2020-01-17 view
JXSL1900136 美泊利单抗注射液 mepolizumab Injection Biological Products Import Drug Application 2019-12-16 GlaxoSmithKline Trading Services Limited Glaxosmithkline Trading Services Ltd In Review 2019-12-14 view
JXSB2101115 美泊利单抗注射液 mepolizumab Injection Biological Products Supplementary Application 2021-12-31 view
CXSL2101358 美泊利单抗注射液 mepolizumab Injection Biological Products(3.3) New Drug Application 2021-10-19 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view